Research Article

MHC I Stabilizing Potential of Computer-Designed Octapeptides

Table 1

Experimentally tested octapeptides. Sequences are given in single-letter code; motif anchor positions fulfilling the SYFPEITHI motif are underlined. S-score: SYFPEITHI score [6]. IEDB-ANN score: predicted IC50 values by IEDB-ANN method [25]. < 500 nM: recommended cutoff for IEDB-ANN score [25] for binders predicted with intermediate affinity; active: IEDB-ANN score < 500 nM; 0: IEDB-ANN score > 500 nM. EC50 values correspond to the peptide concentration required for 50% of maximal MHC I protein stabilization; values in brackets are standard deviations ( 𝑁 = 3 ). n.d.: not detectable.

Peptide numberSequenceS-scoreIEDB-ANN score [ 𝜇 M] < 500 nMExperimental E C 5 0 [ 𝜇 M]

Stabilizing peptides1FRYPYKTL270.5active24.0 ( ± 11)
2FRYIYHTL270.2active20.0 ( ± 4.0)
3FHWDYRGL220.4active25.0 ( ± 11)
4WRFKYDNL222.30 7.0 ( ± 4.0)
5WRFVYWRL201.20 8.0 ( ± 4.0)
6WRFIYFNL210.4active 3.6 ( ± 1.2)
7WDFKFDSV174.70 9.0 ( ± 4.0)
8WKFIFDPV163.00 0.4 ( ± 0.1)
9FHHAHRTV810.50 9.0 ( ± 4.0)

Nonstabilizing peptides of category  (i)10FRYEYRSL280.1activen.d.
11WRYIYHSI222.50n.d.
12HRYVYRNI240.4activen.d.
13FHYAYRSV230.1activen.d.
14YRYKYDRL270.50n.d.
15WRYQYDNL270.70n.d.
16WRYRYWSL270.60n.d.
17WRYNYDPL261.70n.d.
18WRYHYDPL262.40n.d.
19WKYQYDNL270.3activen.d.
20WKYIFDPV221.20n.d.
21WKYPFDPV222.00n.d.

Nonstabilizing peptides of category  (ii)22FRYLYKNA171.20n.d.
23FRYVWRTL181.70n.d.
24FHYLYHTA170.90n.d.
25FRYPYHTP1717.80n.d.
26FRWEYRGL220.70n.d.
27FRHIYRTI189.30n.d.
28FRHGYRQI1812.60n.d.
29FHWAYHTV171.20n.d.
30WRWLYKGV164.30n.d.
31WRFPYDQL216.60n.d.
32WRFKYDPL213.30n.d.
33WRFPYDKL216.80n.d.
34WRFVYDNL211.90n.d.
35WKFKFDPV172.80n.d.
36WKINFDPV178.20n.d.
37TTEWYTKI183.40n.d.

5 of 23 nonstabilizing peptides of category  (iii)38RGEVFTAT1324.00n.d.
39FHYDHRNA96.50n.d.
40HRWVFWQP1126.00n.d.
41SIKNFHYY1213.60n.d.
42FRHDYHSP1129.20n.d.
7 of 120 nonstabilizing peptides of category  (iv)43TVEQGVTQ137.50n.d.
44FHHGHNVP036.80n.d.
45QDGHEIHR138.40n.d.
46TVEQGVTQ137.50n.d.
47GVDQSYLK038.10n.d.
48SVENPILR233.70n.d.
49NEGWTIHR138.80n.d.
50SVDHSIFK236.10n.d.

For category (iii) 5 of 23 octapeptides are given as examples. The remaining 18 octapeptides of category (iii) are listed in Suppl. 2 (Seq. No. 51–68). For category (iv) 7 of 120 ostapeptides are given as examples. The remaining 113 octapeptides of category (iv) are listed in Suppl. 2 (Seq. No. 69–180).